IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 226 filers reported holding IMMUNOMEDICS INC in Q1 2020. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,607,000 | +162.2% | 18,897 | +9.2% | 0.84% | +190.7% |
| Q2 2020 | $613,000 | +160.9% | 17,305 | -0.5% | 0.29% | +199.0% |
| Q1 2020 | $235,000 | -44.3% | 17,397 | -12.7% | 0.10% | +40.6% |
| Q4 2019 | $422,000 | +55.7% | 19,925 | -2.6% | 0.07% | +25.5% |
| Q3 2019 | $271,000 | -9.4% | 20,448 | -5.3% | 0.06% | -12.7% |
| Q2 2019 | $299,000 | +32.3% | 21,587 | +36.2% | 0.06% | +61.5% |
| Q4 2018 | $226,000 | -44.9% | 15,848 | -19.4% | 0.04% | -7.1% |
| Q3 2018 | $410,000 | -48.7% | 19,666 | -41.7% | 0.04% | -94.1% |
| Q2 2018 | $799,000 | -9.4% | 33,761 | -44.1% | 0.71% | -7.7% |
| Q1 2018 | $882,000 | +93.4% | 60,362 | +114.1% | 0.76% | +33.7% |
| Q4 2017 | $456,000 | -23.7% | 28,196 | -34.1% | 0.57% | +606.2% |
| Q3 2017 | $598,000 | +74.3% | 42,784 | +10.1% | 0.08% | +58.8% |
| Q2 2017 | $343,000 | -29.3% | 38,871 | -48.2% | 0.05% | -40.7% |
| Q1 2017 | $485,000 | +94.8% | 75,034 | +10.6% | 0.09% | +16.2% |
| Q4 2016 | $249,000 | -5.3% | 67,841 | -16.3% | 0.07% | -41.7% |
| Q3 2016 | $263,000 | +39.9% | 81,010 | 0.0% | 0.13% | -9.3% |
| Q2 2016 | $188,000 | -13.8% | 81,010 | -7.0% | 0.14% | -53.3% |
| Q1 2016 | $218,000 | -23.2% | 87,062 | -5.9% | 0.30% | -61.5% |
| Q4 2015 | $284,000 | – | 92,480 | – | 0.78% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IFP Advisors, Inc | 0 | $0 | 0.00% |